Bharat Parenterals Limited (BOM:541096)
1,139.95
+39.95 (3.63%)
At close: Jun 27, 2025
Bharat Parenterals Revenue
In the fiscal year ending March 31, 2025, Bharat Parenterals had annual revenue of 3.40B INR with 31.21% growth. Bharat Parenterals had revenue of 1.04B in the quarter ending March 31, 2025, with 48.81% growth.
Revenue
3.40B
Revenue Growth
+31.21%
P/S Ratio
2.31
Revenue / Employee
9.38M
Employees
363
Market Cap
7.86B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 3.40B | 809.71M | 31.21% |
Mar 31, 2024 | 2.59B | 401.05M | 18.29% |
Mar 31, 2023 | 2.19B | 69.72M | 3.28% |
Mar 31, 2022 | 2.12B | 51.08M | 2.46% |
Mar 31, 2021 | 2.07B | -255.76M | -10.99% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,646.93B |
HDFC Bank | 2,728.47B |
Tata Consultancy Services | 2,553.24B |
Bharti Airtel | 1,729.85B |
ICICI Bank | 2,006.54B |
State Bank of India | 3,429.39B |
Infosys | 1,647.16B |
Life Insurance Corporation of India | 8,901.58B |